1. Home
  2. RAVE vs NSRX Comparison

RAVE vs NSRX Comparison

Compare RAVE & NSRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rave Restaurant Group Inc.

RAVE

Rave Restaurant Group Inc.

N/A

Current Price

$3.16

Market Cap

48.5M

ML Signal

N/A

Logo Nasus Pharma Ltd. Ordinary Shares

NSRX

Nasus Pharma Ltd. Ordinary Shares

HOLD

Current Price

$3.02

Market Cap

38.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RAVE
NSRX
Founded
1958
2019
Country
United States
Israel
Employees
N/A
7
Industry
Restaurants
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
48.5M
38.9M
IPO Year
1995
N/A

Fundamental Metrics

Financial Performance
Metric
RAVE
NSRX
Price
$3.16
$3.02
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$19.67
AVG Volume (30 Days)
41.3K
11.6K
Earning Date
05-07-2026
03-25-2026
Dividend Yield
N/A
N/A
EPS Growth
11.76
N/A
EPS
0.15
N/A
Revenue
$15,120,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$20.87
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.25
$1.98
52 Week High
$3.75
$9.99

Technical Indicators

Market Signals
Indicator
RAVE
NSRX
Relative Strength Index (RSI) 47.43 50.48
Support Level $3.07 $2.78
Resistance Level $3.48 $3.60
Average True Range (ATR) 0.15 0.21
MACD -0.03 -0.01
Stochastic Oscillator 25.30 44.60

Price Performance

Historical Comparison
RAVE
NSRX

About RAVE Rave Restaurant Group Inc.

Rave Restaurant Group Inc operates and franchises pizza buffet, delivery/carry-out, express restaurants, and ghost kitchens. It operates restaurants under the brand name, Pizza Inn, and Pie Five Pizza Company. It has three operating segments. The Pizza Inn Franchising and Pie Five Franchising segments establish franchisees, licensees, and territorial rights. The corporate administration and other segments. The Pizza Inn Franchising segment accounts for the majority of the company's revenue. Geographically, it generates the majority of the revenue from the United States.

About NSRX Nasus Pharma Ltd. Ordinary Shares

Nasus Pharma Ltd is a clinical-stage specialty pharmaceutical company focused principally on the development of intranasal drugs to treat emergency medical conditions. It is engaged in developing a number of intranasal powder products based on its a microsphere technology, aimed at assisting patients in several acute emergency situations such as opioid overdose and anaphylactic shock. Its portfolio comprises a number of programs: Intranasal Naloxone completed pivotal study and Intranasal Epinephrine (phase 2) as well as a number of preclinical POC programs.

Share on Social Networks: